A Phase II, Multi-Center, Double-Blind Study of BMS-708163 in the Treatment of Patients with Prodromal Alzheimer's Disease

Study Status: 
Study Description: 

We are now enrolling men and women, ages 45 to 90, with memory loss or mild cognitive impairment (MCI) to participate in this study. A study partner will also be needed to participate in this study. Volunteers may receive investigational medication, study-related medical care, laboratory testing and cognitive testing.

Study Coordinator(s): 

Martha Vander Vliet, RN

Tel:  617-732-8085